Testosterone gel 1.62%
Sponsors
Solvay Pharmaceuticals, AbbVie, VA Office of Research and Development
Conditions
HealthyHypogonadismType 2 Diabetes Mellitus
Phase 1
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
CompletedNCT00998933
Start: 2009-10-31End: 2009-10-31Updated: 2009-11-25
An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier
CompletedNCT01130298
Start: 2010-05-31End: 2010-05-31Updated: 2017-12-07
Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males
CompletedNCT01133548
Start: 2010-05-31End: 2010-07-31Updated: 2017-12-07